Mingjun Zheng

Munich, BY, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 35 publications

Erratum: Overexpression of TMEFF1 in Endometrial Carcinoma and the Mechanism Underlying its Promotion of Malignant Behavior in Cancer Cells: Erratum.

Erratum: Overexpression of TMEFF1 in Endometrial Carcinoma and the Mechanism Underlying its Promotion of Malignant Behavior in Cancer Cells: Erratum.

Journal: Journal of Cancer

Published: April 30, 2025

Necroptosis-Related Gene Signature Predicts Prognosis in Patients with Advanced Ovarian Cancer.

Necroptosis-Related Gene Signature Predicts Prognosis in Patients with Advanced Ovarian Cancer.

Journal: Cancers

Published: December 16, 2024

Retraction notice to "Downregulation of Rab23 inhibits proliferation, invasion, and metastasis of human ovarian cancer" [Int. J. Biochem. Cell Biol. 116 (2019) 105617].

Retraction notice to "Downregulation of Rab23 inhibits proliferation, invasion, and metastasis of human ovarian cancer" [Int. J. Biochem. Cell Biol. 116 (2019) 105617].

Journal: The international journal of biochemistry & cell biology

Published: October 09, 2024

Oxidative Stress Response Biomarkers of Ovarian Cancer Based on Single-Cell and Bulk RNA Sequencing.

Oxidative Stress Response Biomarkers of Ovarian Cancer Based on Single-Cell and Bulk RNA Sequencing.

Journal: Oxidative medicine and cellular longevity

Published: September 08, 2022

HERPUD1 promotes ovarian cancer cell survival by sustaining autophagy and inhibit apoptosis via PI3K/AKT/mTOR and p38 MAPK signaling pathways.

HERPUD1 promotes ovarian cancer cell survival by sustaining autophagy and inhibit apoptosis via PI3K/AKT/mTOR and p38 MAPK signaling pathways.

Journal: BMC cancer

Published: June 11, 2022

ST14 interacts with TMEFF1 and is a predictor of poor prognosis in ovarian cancer.

ST14 interacts with TMEFF1 and is a predictor of poor prognosis in ovarian cancer.

Journal: BMC cancer

Published: June 11, 2022

Interaction between TMEFF1 and AHNAK proteins in ovarian cancer cells: Implications for clinical prognosis.

Interaction between TMEFF1 and AHNAK proteins in ovarian cancer cells: Implications for clinical prognosis.

Journal: International immunopharmacology

Published: November 12, 2021

Identification of the prognostic value of a 2-gene signature of the WNT gene family in UCEC using bioinformatics and real-world data.

Identification of the prognostic value of a 2-gene signature of the WNT gene family in UCEC using bioinformatics and real-world data.

Journal: Cancer cell international

Published: July 23, 2021

Trace Amine-Associated Receptor 1 (TAAR1) Is a Positive Prognosticator for Epithelial Ovarian Cancer.

Trace Amine-Associated Receptor 1 (TAAR1) Is a Positive Prognosticator for Epithelial Ovarian Cancer.

Journal: International journal of molecular sciences

Published: June 23, 2021

Identification of a Novel Tumor Microenvironment Prognostic Signature for Advanced-Stage Serous Ovarian Cancer.

Identification of a Novel Tumor Microenvironment Prognostic Signature for Advanced-Stage Serous Ovarian Cancer.

Journal: Cancers

Published: May 31, 2021

Identification of TMB, CD8 T-cell abundance, and homologous repair pathway mutation frequency as predictors of the benefit-toxicity ratio of anti-PD-1/PD-L1 therapy.

Identification of TMB, CD8 T-cell abundance, and homologous repair pathway mutation frequency as predictors of the benefit-toxicity ratio of anti-PD-1/PD-L1 therapy.

Journal: Clinical and translational medicine

Published: May 27, 2021

Actin Beta-Like 2 as a New Mediator of Proliferation and Migration in Epithelial Ovarian Cancer.

Actin Beta-Like 2 as a New Mediator of Proliferation and Migration in Epithelial Ovarian Cancer.

Journal: Frontiers in oncology

Published: May 21, 2021

Showing 1-12 of 35

Last Updated: 09/26/2026